Cancer predisposition in mutant mice defective in the XPC DNA repair gene

Progress in Experimental Tumor Research

Volumn 35, Issue , 1999, Pages 37-52

  Friedberg, Errol C ^a,b   Cheo, David L ^a   Meira, Lisiane B ^a   Reis, Antonio M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DNA REPAIR; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOUSE; MOUSE MUTANT; MUTATION; REVIEW; SKIN TUMOR; TUMOR SUPPRESSOR GENE; XERODERMA PIGMENTOSUM;

ANIMALS; DNA REPAIR; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM;

EID: 0032605590     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000062011     Document Type: Article

References (45)

1. Friedberg EC, Walker GC, Siede W: DNA Repair and Mutagenesis. Washington, ASM Press, 1995.
2. Cleaver JE, Kraemer KH: Xeroderma pigmentosum, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1989, pp 2949-2971.
3. De Weerd-Kastelein EA, Keijzer W, Bootsma D: Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization. Nat New Biol 1972;238:80-83.
4. Haber D, Harlow E: Tumour-suppressor genes: Evolving definitions in the genomic age. Nat Genet 1997;16:320-322.
5. Kraemer KH, Lee MM, Scotto J: DNA repair protects against cutaneous and internal neoplasia: Evidence from xeroderma pigmentosum. Carcinogenesis 1995;5:511-514.
6. Tyrell RM: Activation of mammalian gene expression by the UV component of sunlight - From models to reality. Bioessays 1996;18:139-148.
7. Nance MA, Berry SA: Cockayne syndrome: Review of 140 cases. Am J Med Genet 1992;42:68-84.
8. Friedberg EC: Cockayne syndrome - A primary defect in DNA repair, transcription, both or neither. Bioessays 1996;18:731-738.
9. Chu G, Mayne L: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy: Do the genes explain the diseases? Trends Genet 1996;12:187-192.
10. Kraemer KH, Levy DD, Parris CN, Gozukara EM, Moriwaki S, Adelberg S, Seidman MM: Xeroderma pigmentosum and related disorders: Examining the linkage between defective DNA repair and cancer. J Invest Dermatol 1994;103:96-101.
11. Venema J, van Hoffen A, Natarajan AT, van Zeeland AA, Mullenders LHF: The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res 1990;18:443-448.
12. Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA, Mullenders LHF: Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol 1991;11:4128-4134.
13. Masutani C, Sugasawa K, Yanigasawa J, Soniyama T, Ui M, Enomoto T, Takio K, Tanaka K, van der Spek PJ, Bootsma D, Hoeijmakers JHJ, Hanaoka F: Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J 1994;13:1831-1843.
14. van der Spek PJ, Eker AP, Rademakers S, Visser C, Sugasawa K, Masutani C, Hanaoka F, Bootsma D, Hoeijmakers JHJ: XPC and human homologs of RAD23: Intracellular localization and relationship to other nucleotide excision repair complexes. Nucleic Acids Res 1996;24:2551-2559.
15. Li L, Lu X, Peterson CD, Legerski R: XPC interacts with both HHR23B and HHR23A in vivo. Mutat Res 1997;383:197-203.
16. Drabkin R, Reardon JT, Ansari A, Huang JC, Zawel L, Ahn K, Sancar A, Reinberg D: Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 1994;368: 769-772.
17. Mu D, Sancar A: Model for XPC-independent transcription-coupled repair of pyrimidine dimers in humans. J Biol Chem 1997;272:7570-7573.
18. Li L, Peterson C, Legerski R: Sequence of the mouse XPC cDNA and genomic structure of the human XPC gene. Nucleic Acids Res 1996;24:1026-1028.
19. Cheo DL, Ruven HJT, Meira LB, Hammer RE, Burns DK, Tappe NJ, van Zeeland AA, Mullenders LHF, Friedberg EC: Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat Res 1997;374:1-9.
20. Sands AT, Abuin A, Sanchez A, Conti JC, Bradley A: High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995;377:162-165.
21. Cheo DL, Meira LB, Hammer RE, Burns DK, Doughty ATB, Friedberg EC: Synergistic interactions between XPC and p53 mutations in double mutant mice: Neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr Biol 1996;6:1691-1694.
22. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
23. Ko LJ, Prives C: p53: Puzzle and paradigm. Genes Dev 1996;10:1054-1072.
24. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC, Montesano R: Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects. Nucleic Acids Res 1997;25:151-157.
25. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10124-10128.
26. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE: Mutation hotspots due to sunlight in the p53 gene on nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993;90:4216-4220.
27. Kraemer KH: Sunlight and skin cancer: Another link revealed. Proc Natl Acad Sci USA 1997;94: 11-14.
28. Meira LB, Cheo DL, Reis A, Hammer RE, Burns DK, Friedberg EC: Genetic interaction between HAP1(REF-1) and p53. Nat Genet 1997;17:145.
29. Cho Y, Gorina S, Jeffrey PD, Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994;265:346-355.
30. Takeuchi S, Nakatsu Y, Nakane H, Murai H, Hirota S, Kitamura Y, Okuyama A, Tanaka K: Strand specificity and absence of hot spots for p53 mutations in UVB-induced skin tumors of XPA-deficient mice. Cancer Res 1998;58:641-646.
31. van Zeeland AA, Mullenders LHF, Zdzienicka MZ, Vrieling H: Influence of strand-specific repair of DNA damage on molecular mutation spectra; in Bohr VA, Wassermann K, Kraemer KH (eds): DNA Repair Mechanisms. Copenhagen, Munksgaard, 1992, pp 117-122.
32. Kondo K, Umemoto A, Akimoto S, Uyama T, Hayashi K, Ohnishi Y, Monden Y: Mutations in the p53 tumor suppressor gene in primary lung cancer in Japan. Biochem Biophys Res Commun 1992;183:1139-1146.
33. Ootsuyama A, Makino H, Nagao M, Ochiai A, Yamauchi Y, Tanooka H: Frequent p53 mutation in mouse tumors induced by repeated β-irradiation. Mol Carcinog 1994;11:236-242.
34. Seki S, Akiyama K, Watanabe S, Hatsushika M, Ikeda S, Tsutsui K: cDNA and deduced amino acid sequence of a mouse DNA repair enzyme (APEX nuclease) with significant homology to Escherichia coli exonuclease III. J Biol Chem 1991;266:20797-20802.
35. Seki S, Ikeda S, Watanabe S, Hatsushika M, Tsutsui K, Akiyama K, Zhang B: A mouse DNA repair enzyme (APEX nuclease) having exonuclease and apurinic/apyrimidinic endonuclease activities: Purification and characterization. Biophys Biochim Acta 1991;1079:57-64.
36. Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T: The redox (DNA repair) protein, Ref-1, is essential for early embryonic development in mice. Proc Natl Acad Sci USA 1996;93:8919-8923.
37. Xanthoudakis S, Curran T: Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA binding activity. EMBO J 1992;11:653-665.
38. Xanthoudakis S, Miao G, Wang F, Pan Y-CE, Curran T: Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992;11:3323-3335.
39. McBride AA, Klausner RD, Howley PM: Conserved cysteine residue in the DNA-binding domain of the bovine papilloma type 1E2 protein confers redox regulation of the DNA-binding activity in vitro. Proc Natl Acad Sci USA 1992;89:7531-7535.
40. Hainaut P, Milner J: Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 1993;53:4469-4473.
41. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, Mann K: Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995;15:3892-3903.
42. Jayaraman L, Murthy KGK, Zhu C, Curran T, Xanthoudakis S, Prives C: Identification of redox/ repair protein Ref-1 as a potent activator of p53. Genes Dev 1997;11:558-570.
43. Nakane H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, Murai H, Nakatsuru Y, Ishikawa T, Hirota S, Kitamura Y, Kato Y, Tsunoda Y, Miyauchi H, Horio T, Tokunaga T, Matsunaga T, Nikaido O, Nishimune Y, Okada Y, Tanaka K: High incidence of ultraviolet-B or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 1995;377:165-168.
44. de Vries A, van Ostrom CThM, Hofhuis FMA, Dortant PM, Berg RJW, de Gruijl FR, Wester PW, van Kreijl CF, Capel PJA, van Steeg H, Verbeek SJ: Increased susceptibility to ultraviolet-B and carcinogenesis of mice lacking the DNA repair gene XPA. Nature 1995;377:169-173.
45. van der Horst GTJ, van Steeg H, Berg RJW, van Gool AJ, de Wit J, Weeda G, Morreau H, Beems RB, van Kreijl CF, de Gruijl FR, Bootsma D, Hoeijmakers JHJ: Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997;89: 425-435.